Amphetamine

Amphetamine

CAS Number:

300-62-9

Batch Molecular Formula:

C9H13N

Batch Molecular Weight:

135.210 g·mol−1

Physical Appearance:

White Crystalline Chips / Powder

Solubility:

Very Soluble in Water

Storage:

Store at RT

Amphetamines represent a class of synthetic central nervous system stimulants with significant medical, clinical, and regulatory implications. These compounds are characterized by their ability to enhance cognitive function, energy levels, and neurological performance, while simultaneously presenting complex physiological and psychological risks.

Amphetamine compounds can be systematically categorized into three primary classifications:

1. Medical Pharmaceutical Formulations

These regulated medications are prescribed under strict medical supervision:

  • Dextroamphetamine (Dexedrine): Primarily indicated for attention deficit disorders and narcolepsy management

  • Mixed Amphetamine Salts (Adderall): Comprehensive treatment for attention deficit hyperactivity disorder

  • Lisdexamfetamine (Vyvanse): Advanced prodrug formulation targeting ADHD and specific metabolic disorders

2. Controlled Substance Derivatives

These variants represent high-risk, non-medical substances:

  • Methamphetamine: An extremely potent and neurologically destructive compound

  • Unregulated Street Formulations: Unpredictable and potentially hazardous chemical compositions

3. Ancillary Pharmaceutical Compounds

Related stimulant substances with peripheral physiological effects:

  • Levoamphetamine: Variant with modified neurological interaction

  • Ephedrine and Pseudoephedrine: Chemically related compounds with distinct pharmaceutical applications

Delphis Pharma – Leading Amphetamine Manufacturer & Contract Manufacturer in India & Global Markets

Delphis Pharma is a trusted manufacturer and contract manufacturer of Amphetamine in India and international markets. We offer custom manufacturing solutions, competitive pricing, and seamless logistics tailored to your needs. Partner with us for high-quality amphetamine production and global supply.

Contact our sales team today for personalized deals and efficient delivery solutions!

Effects

1. Short-term Positive Effects
  • Increased alertness, focus, and energy.

  • Euphoria and enhanced mood.

  • Appetite suppression.

2. Short-term Negative Effects
  • Increased heart rate and blood pressure.

  • Insomnia and anxiety.

  • Dry mouth, dizziness, and irritability.

3. Long-term Effects
  • Dependence and addiction.

  • Cardiovascular problems (e.g., hypertension, heart disease).

  • Neurotoxicity leading to cognitive impairments.

  • Mental health issues (e.g., paranoia, psychosis).

Usage

1. Medical Use
  • ADHD: To improve concentration, attention span, and reduce impulsivity.

  • Narcolepsy: To combat excessive daytime sleepiness.

  • Binge Eating Disorder: (e.g., Vyvanse) to reduce compulsive eating episodes.

2. Non-Medical Use
  • Recreational: For euphoria, enhanced focus, or energy during parties or work.

  • Performance Enhancement: Used by some to improve endurance or cognitive performance (illegally or unethically).

Disclaimer

Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country. Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer’s risk. Most OTC drugs are not reviewed and approved by FDA, however, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies. This is only for study not for any Human / Veterinary use. (Condition Apply)* Delphis Pharmaceutical India warns the buyers / importers not to use/sell/procure any goods to achieve a product which might be knowingly causing an infringement / controlled / banned drugs. Delphis Pharmaceutical India is not responsible or liable for the same.

Disclaimer:

Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country. Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer’s risk. Most OTC drugs are not reviewed and approved by FDA, however, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies. This is only for study not for any Human / Veterinary use. (Condition Apply)* Delphis Pharmaceutical India warns the buyers / importers not to use/sell/procure any goods to achieve a product which might be knowingly causing an infringement / controlled / banned drugs. Delphis Pharmaceutical India is not responsible or liable for the same.

Disclaimer:

Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country. Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer’s risk. Most OTC drugs are not reviewed and approved by FDA, however, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies. This is only for study not for any Human / Veterinary use. (Condition Apply)* Delphis Pharmaceutical India warns the buyers / importers not to use/sell/procure any goods to achieve a product which might be knowingly causing an infringement / controlled / banned drugs. Delphis Pharmaceutical India is not responsible or liable for the same.

Disclaimer:

Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country. Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer’s risk. Most OTC drugs are not reviewed and approved by FDA, however, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies. This is only for study not for any Human / Veterinary use. (Condition Apply)* Delphis Pharmaceutical India warns the buyers / importers not to use/sell/procure any goods to achieve a product which might be knowingly causing an infringement / controlled / banned drugs. Delphis Pharmaceutical India is not responsible or liable for the same.

Disclaimer:

Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country. Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer’s risk. Most OTC drugs are not reviewed and approved by FDA, however, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies. This is only for study not for any Human / Veterinary use. (Condition Apply)* Delphis Pharmaceutical India warns the buyers / importers not to use/sell/procure any goods to achieve a product which might be knowingly causing an infringement / controlled / banned drugs. Delphis Pharmaceutical India is not responsible or liable for the same.